Should You Sell Minerva Neurosciences Inc (NERV) Stock Thursday Morning?

Minerva Neurosciences Inc (NERV) is higher by Thursday morning, with the stock rising 2.96% in pre-market trading to 1.74. NERV's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Biotechnology industry, which ranks 141 out of 146 industries, NERV ranks higher than 2% of stocks. Minerva Neurosciences Inc has fallen 23.53% over the past month, closing at $2.02 on July 15. During this period of time, the stock fell as low as $1.59 and as high as $2.09. NERV has an average analyst recommendation of Buy. The company has an average price target of $6.50.

NERV has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on NERV!

See Full NERV Report

Minerva Neurosciences Inc has a Long-Term Technical rank of 2. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 98% of the market scoring higher. In the Biotechnology industry which is number 137 by this metric, NERV ranks better than 7% of stocks.

Important Dates for Investors in NERV:

-Minerva Neurosciences Inc is set to release earnings on 11/1/2021. During their last earnings release the company posted EPS of $-0.83. -We do not have a set dividend date for Minerva Neurosciences Inc at this time. Click Here To Get The Full Report on Minerva Neurosciences Inc (NERV)